In the Phase 2 trial, participants on the highest dose of retatrutide (12 mg) lost an average of 24.2% of their total body weight over 48 weeks
How Tirzepatide and Semaglutide Help You Lose Weight GLP-1 medications like semaglutide and tirzepatide are FDA approved for adults with a BMI of 30 or more
Is the Wegovy pill covered by Medicare
Although semaglutide (Ozempic/Wegovy) has largely overtaken liraglutide in clinical preference due to its weekly dosing and greater weight loss efficacy, liraglutide retains several advantages: it has over 15 years of post-marketing safety data, cardiovascular outcome data from the landmark LEADER trial, and pediatric approvals for both diabetes and obesity
adults reported taking GLP-1RAs for weight loss, diabetes, or another chronic condition, according to a November 2025 KFF Health Track poll
Canagliflozin and cardiovascular and renal events in type 2 diabetes